Literature DB >> 10497885

Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle.

T C Vary1, S Hazen.   

Abstract

Chronic sepsis promotes a stable increase in pyruvate dehydrogenase kinase (PDHK) activity in skeletal muscle. PDHK is found tightly bound to the pyruvate dehydrogenase (PDH) complex and as free kinase. We investigated the ability of sepsis to modify the activity of the PDHK intrinsic to the PDH and free PDHK. Sepsis was induced by the intraabdominal introduction of a fecal-agar pellet infected with E. coli and B. fragilis. Five days later, mitochondria were isolated from skeletal muscle and PDHK measured in mitochondrial extracts. Sepsis caused an approximate 2-fold stimulation of PDHK. The mitochondrial extracts from control and septic rats were fractionated by gel chromatography on Sephacryl S-300 to separate PDHK intrinsic to PDH complex and free PDHK. PDH complex eluted at void volume and was assayed for PDHK intrinsic to the complex. The activity of PDHK intrinsic to PDH complex was a significantly increased 3 fold during sepsis. Free PDHK activity eluted after the PDH complex and its activity was enhanced by 70% during sepsis. Incubation of PDHK intrinsic to PDH with dichloroactate, an uncompetitive inhibitor of PDHK, showed the PDHK from septic rats relatively less sensitive to inhibition than controls. These results indicate that sepsis induces stable changes in PDHK in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497885     DOI: 10.1023/a:1006993910781

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Evidence that rat liver pyruvate dehydrogenase kinase activator protein is a pyruvate dehydrogenase kinase.

Authors:  S C Mistry; D A Priestman; A L Kerbey; P J Randle
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

2.  Purification and partial characterization of rat liver pyruvate dehydrogenase kinase activator protein (free pyruvate dehydrogenase kinase).

Authors:  D A Priestman; S C Mistry; A L Kerbey; P J Randle
Journal:  FEBS Lett       Date:  1992-08-10       Impact factor: 4.124

3.  Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex.

Authors:  M M Bowker-Kinley; W I Davis; P Wu; R A Harris; K M Popov
Journal:  Biochem J       Date:  1998-01-01       Impact factor: 3.857

4.  Pharmacologic modulation of increased release of gluconeogenic precursors from extra-splanchnic organs in sepsis.

Authors:  T C Vary; R Placko; J H Siegel
Journal:  Circ Shock       Date:  1989-09

5.  Metabolic effects of partial reversal of pyruvate dehydrogenase activity by dichloroacetate in sepsis.

Authors:  T C Vary; J H Siegel; B D Tall; J G Morris
Journal:  Circ Shock       Date:  1988

6.  Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate.

Authors:  T C Vary
Journal:  Shock       Date:  1996-08       Impact factor: 3.454

7.  Early physiologic predictors of injury severity and death in blunt multiple trauma.

Authors:  J H Siegel; A I Rivkind; S Dalal; S Goodarzi
Journal:  Arch Surg       Date:  1990-04

8.  Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A and reduced and oxidized nicotinamide-adenine dinucleotide.

Authors:  A L Kerbey; P J Randle; R H Cooper; S Whitehouse; H T Pask; R M Denton
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

9.  Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids.

Authors:  S Whitehouse; R H Cooper; P J Randle
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

Review 10.  Hypermetabolism-organ failure syndrome: a metabolic response to injury.

Authors:  F B Cerra
Journal:  Crit Care Clin       Date:  1989-04       Impact factor: 3.598

View more
  17 in total

1.  Effects of aerobic training on pyruvate dehydrogenase and pyruvate dehydrogenase kinase in human skeletal muscle.

Authors:  Paul J LeBlanc; Sandra J Peters; Rebecca J Tunstall; David Cameron-Smith; George J F Heigenhauser
Journal:  J Physiol       Date:  2004-03-12       Impact factor: 5.182

2.  Mitochondrial dysfunction and resuscitation in sepsis.

Authors:  Albert J Ruggieri; Richard J Levy; Clifford S Deutschman
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  The Challenge and the Promise of Studying Mitochondrial Dysfunction in Humans with Sepsis.

Authors:  Michael A Puskarich
Journal:  Ann Am Thorac Soc       Date:  2015-11

4.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.

Authors:  Tomas Honzik; Marketa Tesarova; Martin Magner; Johannes Mayr; Pavel Jesina; Katerina Vesela; Laszlo Wenchich; Karol Szentivanyi; Hana Hansikova; Wolfgang Sperl; Jiri Zeman
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

5.  Functional proteomic analysis reveals sex-dependent differences in structural and energy-producing myocardial proteins in rat model of alcoholic cardiomyopathy.

Authors:  Rachel L Fogle; Christopher S Hollenbeak; Bruce A Stanley; Thomas C Vary; Scot R Kimball; Christopher J Lynch
Journal:  Physiol Genomics       Date:  2011-01-18       Impact factor: 3.107

6.  A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle.

Authors:  Hannah Crossland; Dumitru Constantin-Teodosiu; Sheila M Gardiner; Despina Constantin; Paul L Greenhaff
Journal:  J Physiol       Date:  2008-09-25       Impact factor: 5.182

Review 7.  Effect of glucose-insulin-potassium infusion on mortality in critical care settings: a systematic review and meta-analysis.

Authors:  Michael A Puskarich; Michael S Runyon; Stephen Trzeciak; Jeffrey A Kline; Alan E Jones
Journal:  J Clin Pharmacol       Date:  2009-05-05       Impact factor: 3.126

8.  Stimulating pyruvate dehydrogenase complex reduces itaconate levels and enhances TCA cycle anabolic bioenergetics in acutely inflamed monocytes.

Authors:  Xuewei Zhu; David Long; Manal Zabalawi; Brian Ingram; Barbara K Yoza; Peter W Stacpoole; Charles E McCall
Journal:  J Leukoc Biol       Date:  2020-01-02       Impact factor: 4.962

9.  Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.

Authors:  Joanne E Mallinson; Dumitru Constantin-Teodosiu; Philip D Glaves; Elizabeth A Martin; Wendy J Davies; F Russell Westwood; James E Sidaway; Paul L Greenhaff
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

10.  Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.

Authors:  Heleen M Oudemans-van Straaten; Marlies Ostermann
Journal:  Crit Care       Date:  2012-12-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.